Mobiele menu

Background image Background image darkmode

Immunotherapy of lung cancer: identification of the immune response against lung cancer antigens and proof-of-principle of therapeutic vaccination strategies

Producten

Titel: Endosonography for the diagnosis of (recurrent) malignant lymphoma presenting with mediastinal lymphadenopathy
Titel: Endosonography for lung cancer staging: predictors for false-negative outcomes.
Auteur: Talebian Yazdi M., Egberts J., Schinkelshoek M.S., Wolterbeek R., Nabers J., Venmans B.J.W., Tournoy K.G., Annema JT
Magazine: Lung Cancer
Titel: EUS-FNA in the preoperative staging of non-small cell lung cancer
Auteur: 6. Talebian Yazdi M, von Bartheld MB, Braun J, MI Versteegh, Rabe KF, Annema JT
Magazine: Lung Cancer
Titel: Abstract 2923, Title: XAGE-1b and p53: Potential targets for immunotherapy of non-small cell lung cancer (NSCLC)
Titel: Local and systemic XAGE-1b-specific immunity in patients with lung adenocarcinoma.
Auteur: Talebian Yazdi M, Loof NM, Franken KL, Taube C, Oostendorp J, Hiemstra PS, Welters MJ, van der Burg SH
Magazine: Cancer immunology and immunotherapy
Titel: Title: Potential targets for immunotherapy of non-small cell lung cancer: XAGE-1b and p53
Titel: Recent progress in peptide vaccination in cancer with a focus on non-small cell lung cancer
Auteur: Talebian Yazdi M, Keene K, Hiemstra PS, van der Burg SH
Magazine: Expert Reviews of Vaccines
Titel: The positive prognostic effect of stromal CD8+ tumor-infiltrating T cells is restrained by the expression of HLA-E in non-small cell lung carcinoma
Auteur: Mehrdad Talebian Yazdi, Sander van Riet, Annemarie van Schadewijk, Marta Fiocco, Thorbald van Hall, Christian Taube, Pieter S. Hiemstra, Sjoerd H. van der Burg
Magazine: Oncotarget

Snel naar

Kenmerken

Projectnummer:
92003578
Looptijd: 100%
Looptijd: 100 %
2011
2015
Gerelateerde programma's:
Gerelateerde subsidieronde:
Projectleider en penvoerder:
Dr. L.N.A. Willems
Verantwoordelijke organisatie:
Leiden University Medical Center